A prospective phase 2 study of expeditious EGFR genotyping and immediate therapeutic initiation through extracellular vesicles (EV)-based bronchoalveolar lavage fluid (BALF) liquid biopsy in advanced NSCLC patients

BACKGROUND: In our previous study, epidermal growth factor receptor (EGFR) genotyping using extracellular vesicles (EV)-derived DNA isolated from bronchoalveolar lavage fluid (BALF) was proven to be highly concordant with conventional tissue-based genotyping and its turn-around-time (TAT) was only 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, In Ae, Hur, Jae Young, Kim, Hee Joung, Kim, Wan Seop, Lee, Kye Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413015/
https://www.ncbi.nlm.nih.gov/pubmed/37577304
http://dx.doi.org/10.21037/tlcr-22-892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413015/
https://www.ncbi.nlm.nih.gov/pubmed/37577304
http://dx.doi.org/10.21037/tlcr-22-892

Ejemplares similares